Globus Medical EBITDA 2010-2024 | GMED

Globus Medical annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Globus Medical EBITDA for the quarter ending September 30, 2024 was $0.182B, a 221.04% increase year-over-year.
  • Globus Medical EBITDA for the twelve months ending September 30, 2024 was $0.622B, a 115.63% increase year-over-year.
  • Globus Medical 2023 annual EBITDA was $0.359B, a 18.87% increase from 2022.
  • Globus Medical 2022 annual EBITDA was $0.302B, a 23.3% increase from 2021.
  • Globus Medical 2021 annual EBITDA was $0.245B, a 39.86% increase from 2020.
Globus Medical Annual EBITDA
(Millions of US $)
2023 $359
2022 $302
2021 $245
2020 $175
2019 $224
2018 $213
2017 $207
2016 $200
2015 $200
2014 $163
2013 $123
2012 $133
2011 $114
2010 $103
2009 $95
Globus Medical Quarterly EBITDA
(Millions of US $)
2024-09-30 $182
2024-06-30 $174
2024-03-31 $124
2023-12-31 $142
2023-09-30 $57
2023-06-30 $85
2023-03-31 $75
2022-12-31 $72
2022-09-30 $79
2022-06-30 $86
2022-03-31 $65
2021-12-31 $36
2021-09-30 $71
2021-06-30 $66
2021-03-31 $72
2020-12-31 $76
2020-09-30 $66
2020-06-30 $-10
2020-03-31 $43
2019-12-31 $64
2019-09-30 $55
2019-06-30 $55
2019-03-31 $49
2018-12-31 $55
2018-09-30 $49
2018-06-30 $53
2018-03-31 $56
2017-12-31 $58
2017-09-30 $47
2017-06-30 $49
2017-03-31 $54
2016-12-31 $57
2016-09-30 $46
2016-06-30 $46
2016-03-31 $50
2015-12-31 $63
2015-09-30 $48
2015-06-30 $44
2015-03-31 $45
2014-12-31 $46
2014-09-30 $41
2014-06-30 $38
2014-03-31 $38
2013-12-31 $38
2013-09-30 $35
2013-06-30 $17
2013-03-31 $34
2012-12-31 $34
2012-09-30 $32
2012-06-30 $35
2012-03-31 $32
2011-12-31 $28
2011-09-30 $31
2011-06-30 $28
2011-03-31 $27
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.424B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.706B 24.73
Intuitive Surgical (ISRG) United States $193.352B 101.09
Alcon (ALC) Switzerland $43.519B 29.12
Edwards Lifesciences (EW) United States $41.599B 26.42
IQVIA Holdings (IQV) United States $36.625B 20.18
IDEXX Laboratories (IDXX) United States $35.273B 41.54
DexCom (DXCM) United States $30.978B 46.65
Waters (WAT) United States $22.985B 33.99
STERIS (STE) Ireland $21.603B 24.87
SONOVA HOLDING (SONVY) Switzerland $20.257B 0.00
Hologic (HOLX) United States $17.928B 19.36
Fresenius Medical Care AG KGaA (FMS) Germany $13.368B 13.72
Sysmex ADR (SSMXY) Japan $13.192B 41.37
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.192B 44.48
Teleflex (TFX) United States $9.024B 14.39
Glaukos (GKOS) United States $7.669B 0.00
PROCEPT BioRobotics (PRCT) United States $5.015B 0.00
Integer Holdings (ITGR) United States $4.655B 26.38
Veracyte (VCYT) United States $3.419B 102.61
Inari Medical (NARI) United States $3.051B 0.00
TransMedics (TMDX) United States $2.857B 90.57
LivaNova (LIVN) United Kingdom $2.839B 16.39
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.209B 19.86
Tandem Diabetes Care (TNDM) United States $2.135B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.848B 0.00
Alphatec Holdings (ATEC) United States $1.448B 0.00
Pulse Biosciences (PLSE) United States $1.284B 0.00
Artivion (AORT) United States $1.242B 82.28
OPKO Health (OPK) United States $1.044B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.901B 15.31
Paragon 28 (FNA) United States $0.864B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.738B 0.00
IRadimed (IRMD) United States $0.682B 36.87
Mesa Laboratories (MLAB) United States $0.660B 15.55
AxoGen (AXGN) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.561B 0.00
Treace Medical Concepts (TMCI) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Semler Scientific (SMLR) United States $0.503B 29.61
Tactile Systems Technology (TCMD) United States $0.446B 24.14
Delcath Systems (DCTH) United States $0.404B 0.00
CVRx (CVRX) United States $0.377B 0.00
ClearPoint Neuro (CLPT) United States $0.338B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.241B 0.00
Accuray (ARAY) United States $0.216B 0.00
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.160B 0.00
Atossa Genetics (ATOS) United States $0.160B 0.00
Sensus Healthcare (SRTS) United States $0.140B 15.02
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.100B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.088B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Vicarious Surgical (RBOT) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
Lucid Diagnostics (LUCD) United States $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00